Abstract
In an age when multitasking is the norm and “to-do” lists seem longer than ever, it helps to take a step back and focus on what’s important. CPNP is doing just that by devoting August’s MHC to the topic of “Psychotropics in the Child-Bearing Woman”. What could be more important than protecting the health and well-being of an unborn baby by safely managing Mom’s mental illness? For example, avoiding well-known teratogens such as valproate can decrease the risk of autism spectrum disorder and developmental delay. CPNP members are frequently called upon to recommend pharmacotherapy during pregnancy and lactation.This issue of the MHC will provide members with the most current information to help patients, their families and care providers make informed decisions about psychotropic drug use in pregnancy.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
